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ABSTRACT
The advent of molecular science has opened research into the role of the immune system in regulating
growth and development. The primary functions of the immune system are to maintain the integrity of
the organism and to eliminate any foreign invaders. In the case of mammals, pregnancy produces a
paradox. The developing embryo is a foreign body; yet, it is nurtured rather than being rejected. The
immune system is fundamental to the operation of this unique interaction of maternal and fetal cells.
The ultimate paradox is that if maternal and paternal immunity are too similar, pregnancy fails.
Cytokines, recently discovered chemical messengers, are intimately associated with the immune
system, functioning as regulators of development according to specific time and space. Our knowledge
regarding the number and nature of growth factors and cytokines is increasing. Regulation of these
factors is critical to proper growth and development. Interruption of any part of this complex system
causes pregnancy to fail. Mammalian pregnancy is a unique, intricately designed system, a tribute to a
Master Designer.
INTRODUCTION
During the Fifties and Sixties, with the advent of molecular science, much new information about
immunity was gained. At this time transplant science was a new and growing field. This development
opened many questions about fetal development and how an embryo can survive within an environment
in which it is a foreign tissue. The study of tumor survival and rejection increased the number of
questions regarding fetal development. In the Eighties, a new branch of science arose: embryo
transplant. This made the pregnancy paradox even more striking. How can a totally foreign embryo
survive in an apparently hostile environment? Not only does it survive; but also, mechanisms are in
place which allow it to grow and develop. Contrary to being rejected, it is nurtured by the mother's body.
The immune system plays a vital role in this development, paradoxically controlling systematic
development and preventing rejection.

The main function of the immune system is the recognition of self. A complex self-recognition system of
cells and soluble factors is present within all living organisms and is most highly developed in mammals,
especially humans. These products recognize foreign invaders and remove them by a variety of means.
The unique ability of an individual's immune system to recognize self is based on the molecular
specificity of a cell membrane protein entity called the Major Histocompatability complex (MHC). In
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humans several MHC moieties have been described: HLA-A, B, C, D, and a unique monomorphic type
found on the placenta called HLA-G. MHC is produced by highly polymorphic genes at several loci.
Class II MHC is expressed on specialized cells which serve as antigen presenting cells. Two classes of
MHC are universally recognized. Individuals possess a unique class I MHC which is expressed on
almost all nucleated cells except sperm and placental cells. Class II MHC is expressed on specialized
cells which serve as antigen presenting cells. The polymorphic nature of MHC accounts for the ability of
the immune system to distinguish self from non-self, since a vast number of combinations are possible.
T-Iymphocytes produce specific unique membrane receptors which recognize antigen associated with
MHC. This leads to proliferation of T cells and effecter cells. T cells produce glycoproteins, or
cytokines, identified as CO-1 ,2,3,4, and 8. They also produce a substance known as integrin. Three
subgroups of T cells have been identified. One group, T-Helper Cells, (TH cells) manufacture and
secrete CD-4 which activates cells of the immune system. Under the influence of TH, a second
subgroup, Cytotoxic T-Cells (TC) proliferate into Cytotoxic T Lymphocytes (CTL). TH cells are activated
only when antigen is displayed on specific Antigen Presenting Cells (APC) . These are macrophages, B
lymphocytes, and dendritic cells. The third subgroup is identified as T Suppressor Cells (TS) . At the
present time there is some controversy as to the existence of this subset.
Cellular interactions between TH cells, APC's, and B cells are required for generation of an immune
response. Antigen must be presented with a MHC molecule on the membrane of an appropriate APC,
particularly macrophages, which secrete interleukin and interferon. The antigen specific TH cell binds to
antigen-MHC complex and secretes cytokines. These activate B cells, which then undergo cell division
to produce more B cells. Three cytokines are secreted. Interleukin -1 (IL-1) induces the production of B
cells. IL-II and interferon y activate macrophages to become Natural Killer Cells (NKs). MHC functions
to present non-self antigen. A class III MHC has been identified, with possibly a regulatory function .
Three interferon factors have been identified, IFN a,p, and y. These and Tumor Necrosis Factor (TNF)
increase the expression of MHC class I and II and regulate phagocytes and monocytes. IFN y
augments expression of adhesion factors and suppresses the action of NK cells. IL-4 increases the
expression of Class II MHC on resting B cells, leading to and increased production of B cells and
increased membrane receptiveness. It favors the growth of TH cells, the source of IL-4, and inhibits
the production of IFN y. It also plays a role in creating an isotope switch from the production of IgG-2 to
the manufacture of IgE and Ig G-1. This switches antibody production away from cellular components
and toward humoral components. IFN y and IL-4 have opposite effects and antagonize each other.
There is a well developed time-space regulation of the immune response. This is accomplished by the
following mechanisms. First B cells have a very short life span, so the proteins spontaneously decay
rapidly. Second, there is a destabilization and inhibition of activated factors. Third, activated factors are
destroyed by proteolytic cleavage.
HORMOMES, CYTOKINES, AND OTHER MOIETIES
Within the last ten years, many new chemical messengers have been discovered. Our understanding of
the role these moieties play in cellular processes is still in its infancy. Gaining information in this area is
difficult because these messengers exist for a very limited time, and tracking them requires intact whole
organisms; although innoculating cell cultures has added a great deal of knowledge about how these
chemicals work.

In early pregnancy, estrogen stimulates the release of several cytokines which prepare the uterus for
the implanting embryo. These include Epidermal Growth Factor (EGF) Transforming Growth Factor
(TGF), Leukemia Inhibiting Factor (LlF) , Interleukin (IL), Interferon ( IFN), and Colony Stimulating
Hormone (CSF). As implantation proceeds, the level of estrogen decreases and the level of
progesterone increases. This changes the physiology from one favoring implantation to one favoring
growth and maintenance. Prostaglandins inhibit the production and action of interleukin, which serves
to regulate inflammation and provide immunosuppression by inhibiting the production of Cytotoxic
Lymphocytes. Prostaglandins also stimulate vascular development of the uterine wall, known as
decidualization. Insulin Like Growth Factors (IGF) are secreted by the placenta during placental
differentiation and influence growth and development.
Early embryo growth and uterine invasion have been compared to tumor and graft immunology,
although the maternal-fetal relationship is far more complicated than a tumor or allograft reaction. The
term "allograft" implies that the fetal environment is hostile and must be overcome. There are
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similarities between the immunity of tumors and the immunity of pregnancy, but the environment of the
uterus is very specific and the comparison to graft or tumor immunology is weak. A new term for the
special fetal environment recognizes the beneficial interaction between the fetus and the mother. This
term is "constructive or programmed symbiosis." Even this term is inadequate, since the fetus does not
benefit the mother in a symbiotic relationship. While comparison of embryonic tissues with tumors has
led to an understanding of the process of invasion and implantation, comparison with graft immunology
has led to an understanding of fetal survival. The MHC plays an important role in graft survival or
rejection . In order to elicit an immune response, the target cells must express both class I and class II
MHC, which are recognized as foreign , setting up an immune response leading to rejection of the graft.
Activated TH cells secrete IL-2, inducing the production of cytotoxic T lymphocytes. These cells react
with the class I MHC of the graft, destroying it. Concurrently, IL-2 and IL-4 are produced by B
lymphocytes to produce antibodies. Cells recognized by these antibodies are destroyed . A second
graft is then rejected more quickly because of antibody memory. These elements of the immune system
playa vital role in the development of the placenta, which is the lifeline between the growing infant and
the endometrium. Immunosuppression is a factor in the survival of the fetus, but this is not the only
factor. It is well known that the mother does not exhibit any compromised immune capability during
pregnancy. Furthermore, the immune system plays a role in growth and organization of the mature
organism. Undifferentiated embryonic cells implanted into a kidney, for instance, develop in a random
manner and produce a jumbled mass of cell types. In the proper time-space relationship, the immune
system is part of an intricate communication network which is necessary for organized growth and
development. In the uterus, no class II MHC is expressed; but rather, only a unique monomorphic class
I. In the uterus, IL-4 stimulates an isotope switch from IgG-2 to IgG- 1. By binding complement, T cells
are inhibited from becoming NK cells. This favors the growth of TH-2 cells over TH- 1 cells and
stimulates TH-2 proliferation. A coordinated production of these various factors controls the time-space
invasion of trophoblast into the decidua.
IMPLANTATION AND INVASION
The placenta confronts the maternal immune system at two times. The first time occurs when the
peripheral trophoblastic cells of the placenta break through the uterine epithelial basement membrane
and invade the uterine stroma, which contains lymphocytes and immigrant leucocytes. The second
occurs at the cytotrophoblastic placenta during development of the hemochorial placenta. An immune
response is generated by the mother at these times. This inflammatory response leads to
decidualization of the endometrium. Interaction between the uterine endometrium and the blastocyst
results in a regulatory system that allows blastocyst survival and growth.
Implantation requires an immune response by the maternal tissues. This takes place within a
prescribed time-space relationship during which migration, adhesion, and apoptosis (or self-destruction)
occur, without eliciting an immune response which would destroy the embryonic tissue. The placenta
also generates an immune response. Several cellular types make up the placenta, collectively called
the trophoblast. Cytotrophoblast and chorionic trophoblast invade the hormonally prepared uterine wall,
called the decidua. First trimester trophoblast cells show many factors enabling invasion and growth.
The list of factors is long and growing. Degradative enzymes secreted by early trophoblast include
several extracellular matrix ligands and integrins. Cytotrophoblast cells which adhere to the basement
membrane express a. and y integrin . It also appears that theses cells actually produce the basement
membrane. Cytotrophoblast column cells express fibronectin rather than integrin. These factors are
precisely regulated and produce opposite effects. Research shows that integrins, termed a. 5/,131,
interacting with fibronectin inhibit invasion, while integrins, termed a 1/,131 and a. 6/ 13 1, interacting with
laminin enhance invasion. Transition of integrin type is essential to pregnancy. If it is not normal,
invasion is too shallow, leading to abortion.
An adhesion factor, E cadhedron, is important in maintaining cell-cell adhesion. Estrogens secreted by
the blastocyst on days 1 and 2 of pregnancy induce the uterine epithelium to produce EGF, TGF, and
Leukemia Inhibiting Factor (LlF). EGF is expressed only at the site of blastocyst adhesion. The
function of EGF appears to be the induction of proliferation of epithelial cells, resulting in the formation
of the decidua. LlF also inhibits differentiation of trophectoderm and is necessary for implantation. It
appears to be regulatory in function, co-ordinating cellular processes between the implanting blastocyst
and the transforming uterine epithelium. The production of LlF is induced by maternal estrogen. This
was shown by H. Blatt, and referred to by Stewart [13, p. 160). The study used overectomized mice,
which do not produce LlF. Estrogen induces the production of an adhesion factor, CAM 1, which is
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responsible for adhesion of the blastocyst to the endometrium. By day 3, CAM 1 is inhibited
byprogesterone. CAM 1 and glycans secreted by the endometrium cause dissociation of endometrial
cells, allowing implantation.
Normal cells within a tissue adhere to each other and to the extracellular matrix. Integrins are cell
surface molecules which anchor cells to the extracellular matrix. Cells lacking the necessary adhesion
factors self-destruct. In order to survive, cells must have the proper adhesion molecules for their time
and space. This property of cells is responsible for the death of abnormal cells which attempt to float
away from their parent tissue and metastasize to other tissues. Enzymes classed as metalloproteinases
are capable of dissolving the basement membrane, enabling invasion in a new site. Cancer cells,
which contain metalloproteins, are capable of overcoming the need for adhesion factors. Then, at the
site of metastasis, they produce adhesion molecules which recognize targets on cells at the new site.
Tumor cells express transferrin and alkaline phosphatase which aid in the process of invasion by
upgrading anabolic activities as well as the transfer of iron. Malignant cells produce an antigen known
as CO-46. It is associated with MHC-I on the cell surface and is thought to playa role in preventing an
immune reaction between the foreign cells and the host immune system. A similar antigen, COX, is
associated with placental trophoblast cells. Trophoblast also expresses transferrin and alkaline
phosphatase. These enzymes control metabolism, so they are necessary for the growth of fetal tissues.
The invading cytotrophoblast synthesizes several metalloproteinases and collaginases. These are all
under the control of estrogen. The timing of the estrogen surge, the production of LlF and EGF plus
the controlled presence of degradating enzymes allows adhesion and invasion in exactly the proper
balance.
An immune response by the uterine epithelium is necessary for proper anchoring of the trophoblast to
the decidua. The basal plate is a fibrin mesh of fetal and maternal fibrin . Thrombomodulin, an
endothelial receptor, binds thrombin, preventing the conversion of fibrinogen to fibrin . IL-I
down-regulates thrombomodulin allowing the production of fibrin to proceed. IL-1 is stimulated by
antigenic recognition which cause TH cells to release macrophage-activation factors that cause
macrophages to release IL- 1.
Low Density Lipoproteins (LOL) have been discovered which affect implantation and placentation.
Several lipoprotein particles have been discovered. All are similar in structure even though they are
produced by the action of several different genes. They have a specific area of function , yet their
functions appear to overlap. LOL receptors are found on tumor cells as well as on many other cells in
the body. Studies of placental LOL receptors have shown them to be expressed in distinctive patterns
which change with time and space. One, identified as Gp 330, is extensively expressed in
pre-implantation trophoblast but not after implantation. Another, identified as LRP, is found on villous
cytotrophoblast and syncytiotrophoblast at implantation sites. As pregnancy advances, it is found only
on the syncytiotrophoblast. Various members of the LOL receptors control invasion, regulate general
secondary carriers which change cell function and affect metabolism within the extracellular matrix.
These are important functions during implantation. LOLs also affect the synthesis of steroids by the
placenta.
AS invasion progresses, trophoblast cells induce changes in the endometrium, resulting in the formation
of the decidua. The endometrium also plays an active role in this process. Colony Stimulating Factor
(CSF-1) receptors are found on trophoblast cells while their ligands are produced by uterine endothelial
cells. CSF-1 expression is induced by an interaction of progesterone and estrogen. McMasters, [9,pp.
125-127), determined that essential growth factors, Epidermal Growth Factor and Transforming Growth
Factor, which are produced by trophoblast cells only in the presence of receptors in maternal decidua,
are the source of the ligand. EGF allows differentiation of the trophoblast into the syncytium.
Cytotrophoblast produces Interleukin 1-13 and also IL 1-13 receptor. Uterine cells also produce and
respond to IL-1 p. This allows a coordinated development of both decidua and trophoblast. EGF
increases the production of Human Chorionic Gonadotropon and hPL (Human Placental Lactogen) .
Anti-hPL antibodies are found on invading cytoytrophoblasts which are in contact with the basement
membrane of the uterine epithelium. Transcription factor OCT-4 is expressed by the blastocyct. This
factor represses the activity of IFN-- y and hCG. This is thought to be a control factor for trophectoderm
differentiation and growth.
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THE PARADOX
Early thoughts that paternal antigens were not expressed, or were suppressed, have been proven
inaccurate. Research with women who experience repeated abortions have shown that paternal
antigen expression is actually important for successful pregnancy. The decidual response to paternal
antigen stimulates the production of T cells. These T cells respond to class II antigen, and produce
antibodies specific to paternal B lymphocytes. This blocks Iymphocytotoxic activity of antipaternal
antibodies by blocking the response to IL-2. A significant study done by Thomas, and noted by Beer,
[1, p. 122] showed that couples sharing MHC types HLA A, B, or DR, were more likely to experience
abortions. If maternal and paternal antigens are similar, a T cell proliferation does not occur, and the
decidua does not produce suppressor cells, and pregnancy fails. Blocking of immunological responses
makes the uterus a "privileged site". Grafts of fetal or paternal tissue are rejected if placed in
extrauterine sites. Lymphocytic bone marrow-derived suppressor cells are found in the decidua of
women carrying successful pregnancies. These suppressor cells block cytotoxic T activity against
paternal antigens. IgG secreted by the endometrium, and responsible for the transfer of antibody to the
fetus, expresses a moiety known as FcR. Fc is an active chain found on Ig. FcR is a receptor for Fc.
FcR, expressed by trophoblast cells, neutralizes complement fixation , masks surface antigens, and
prevents direct contact of the trophoblast with the decidua. This provides a unique escape mechanism
for avoiding a harmful immune reaction between the invasive trophoblast and the decidua. It also
provides a positive pathway for the transfer of essential products for fetal survival.

Women carrying successful pregnancies produce anti-B antibodies blocking reaction specifically to
paternal antigens. Maternal response to tissue specific antigens of the trophoblast,
Trophoblast-Lymphocyte Cross-Reactive Antigen, (TLX) is necessary to maintain pregnancy. When the
maternal immune system comes in contact with paternal TLX on trophoblast cells, an anti-TLX response
is mounted. This in turn stimulates an anti-anti-TLX response which blocks the first response. If mates
are TLX compatible, neither response is stimulated and the pregnancy fails due to an uninhibited
production of NK cells. Some women produce an anti TLX response, but not an anti-anti TLX response.
In these cases pregnancy fails also: thus, both responses are essential.
The placenta is resistant to antibodies. Wood [15, pp. 235-248] noted that human cytotrophoblast cells
express a unique monomorphic class I MHC, and no class II. In fact, trophoblast cells cannot be
induced to produce polymorphic class I HLA. In addition, a suppressor factor, identified as Suppressor
Inducer Factor (SIF) has been isolated from trophoblast ceilis. This is bound to IgG 1, an antibody also
found in surviving tumors. IgG-l is not complement fixing, and plays a role in antibody transfer to the
fetus. IgG-2, a potential source of anti-fetal antibodies, is not produced by the mother. Prostaglandins
produced by the decidua have been shown to enhance antibodies which inhibit the expression of IL-2
and IFN y by NK lymphocytes. IL-2 is dependent on the presence of 2 signals: T cell Growth Factor and
T Helper Factor. Antigen stimulates TCGF which in turn stimulates Helper cells to produce IL-2. This
data has shown that, although TCGF is expressed, IL-2 is inhibited.
.
CONCLUSION
The uterus has been called a "privileged site" because of the endometrium's uterine-specific immune
factors which enable it to bypass rejection mechanisms. However, this is only part of the process. An
immune difference between the two parents is actually necessary in order to establish a pregnancy.
Merely accepting the foreign embryo, though, does not complete the process. The embryo must be
nurtured. This is accomplished by a coordinated procession of immune factors and cytokines which
enable the placenta, a tissue of fetal origin, to adhere, implant, and invade the uterine stroma. An
intricate communication system is prerequisite if this process is to occur in an orderly fashion. The
window for implantation is short. If the proper sequence factors is not available at exactly the right time,
pregnancy will fail. Factors can not be deficient, or overproduced. Intricate balance according to time
and space is essential. The embryo also contributes to this cytokine orchestration. Numerous fetal
immune factors are produced early in gestation. These, interacting with immune factors produced by
the mother, allow the placenta to develop smoothly with precise regulation which controls and changes
the uterine physiology as needed throughout the pregnancy. Every moiety of this complex mechanism
must be in place simultaneously. Any errors result in unsuccessful pregnancy. Mammalian pregnancy
requires a vast amount of information, a system for dispensing and regulating this information, and
physical plant in which this information is used. Since all meaningful information comes from an
intelligent source, this complex precise system is a tribute to a Master Designer.
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